STUDY OF MECHANISMS OF DIFFERENTIATION AND RESISTANCE TO ANTI-CANCER AGENT OF EMBRYONAL CARCINOMA CELLS
STUDY OF MECHANISMS OF DIFFERENTIATION AND RESISTANCE TO ANTI-CANCER AGENT OF EMBRYONAL CARCINOMA CELLS
批准号:
09672046
负责人:
MORITA Takashi
金额:
$1.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
(1)我们证明了顺铂在畸胎癌F9细胞中诱导生长抑制并随后诱导分化。本研究以p34^<cdc2>的改变为重点,探讨顺铂对F9细胞周期进程的影响机制。经处理后,cdc2 mRNA的表达水平没有变化,但p34^<cdc2>的半衰期大大缩短,导致细胞周期阻滞在S晚期至G2/M。(2)哺乳动物Rad51基因是酵母Rad5l和大肠杆菌RecA基因的同源基因,与DNA双链断裂修复有关,也参与g辐照和抗癌剂等烷基化剂对DNA损伤的重组修复和各种SOS反应。在本研究中,我们证明了Rad51反义寡核苷酸在体内和体外增强小鼠恶性胶质瘤的放射敏感性,提示通过抑制DNA双链断裂修复来增强恶性胶质瘤的放射治疗。
英文摘要
(1) We demonstrated that cisplatin induced growth suppression followed by induction of differentiation in teratocarcinoma F9 cells. In this study, we investigated the mechanism of the effect of cisplatin for cell cycle progression in F9 cells focusing on the change of p34^<cdc2>. By the treatment, the level of the expressionof cdc2 mRNA did not change, but the half life of p34^<cdc2> was greatly reduced, which would result in the arrest the cell cycle at the late S to G2/M.(2) The mammalian Rad51 gene is a homolog of the yeast Rad5l and E.coli RecA genes, which are related to the repair of DNA double-strand breaks and are also involved in recombination repair and various SOS responses to DNA damage by g-irradiation and alkylating agent like anticancer agent. In this study, we demonstrated that Rad51 antisense oligonucleotides enhances the radiosensityivity of mouse malignant gliomas in vivo and in vitro, suggesting the potentiation for radiation therapy in malignant gliomas by inhibiting DNA double-strand break repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yoshida K.et al: "The Mouse RecA-like Gene,DmcI is required for recognition of homologs in meiotic synapssis." Mol Cell. (in press). (1998)
Yoshida K.等人:“小鼠 RecA 样基因 DmcI 是减数分裂突触中同系物识别所必需的。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yosida,et al.: "The Mouse RecA-like Gene,Dmcl is required for homologous chromosome synapsis during meiosis." Mol.Cell. 1. 707-718 (1998)
Yosida 等人:“减数分裂过程中同源染色体突触需要小鼠 RecA 样基因 Dmcl。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohnishi,T.et al.: "In Vitro and in Vivo Potentiation of Radiosensitivity of Malignant Gliomas by Antisense Inhibition of the RAD51 Gene." Biochem.Biophys.Res.Commun.245. 319-324 (1998)
Ohnishi,T.et al.:“通过反义抑制 RAD51 基因在体外和体内增强恶性神经胶质瘤的放射敏感性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshida, K., Kondoh, G., Matsuda, Y., Habu, T., Nishimune, T., Morita, T.: "The mouse RecA-like Gene, Dmcl is required for homologous chromosome synapsis during meiosis." Mol.Cell. 1. 707-718 (1998)
Yoshida, K.、Kondoh, G.、Matsuda, Y.、Habu, T.、Nishimune, T.、Morita, T.:“小鼠 RecA 样基因 Dmcl 是减数分裂过程中同源染色体突触所必需的。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohnishi,T.et al.: "In Vitro and in Vivo Potentiation of Radiosensitivity of Malignant Gliomas by Antisense Inhibition of the RAD51 Gene." Biochem. Biophys.Res.Commun.245. 319-324 (1998)
Ohnishi,T.et al.:“通过反义抑制 RAD51 基因在体外和体内增强恶性神经胶质瘤的放射敏感性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Study of space radiation using ES cells
-
批准号:24620007
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.58万
-
财政年份:2012
-
负责人:MORITA Takashi
-
依托单位:
Reflection on the Evolution of Cartographic Theories of Jacques Bertin
-
批准号:23501251
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.0万
-
财政年份:2011
-
负责人:MORITA Takashi
-
依托单位:
Comprehensive study to explore new physiologically active proteins in the snake venoms in the tropical and subtropical regions
-
批准号:19406002
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.91万
-
财政年份:2007
-
负责人:MORITA Takashi
-
依托单位:
Studies on the structure and function of new vascular endothelial growth factors
-
批准号:18370048
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.47万
-
财政年份:2006
-
负责人:MORITA Takashi
-
依托单位:
Functions of Real Scale Map and Their Use in Ubiquitous Mapping
-
批准号:17500709
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:2005
-
负责人:MORITA Takashi
-
依托单位:
Current Situation and Future Perspectives of the Horizon of 2010 of Japanese Cartogrphy
-
批准号:14580107
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:2002
-
负责人:MORITA Takashi
-
依托单位:
Studies on the crystal structure of clotting factors and its binding proteins.
-
批准号:13480197
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2001
-
负责人:MORITA Takashi
-
依托单位:
Research on establishment of the sustainable and labor-saving cultivation system of taro.
-
批准号:13660029
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:MORITA Takashi
-
依托单位:
Investigation and biochemical study of novel neurotoxins and thrombo-toxin from the venoms of Elapidae and Viperidae snakes.
-
批准号:12575035
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.87万
-
财政年份:2000
-
负责人:MORITA Takashi
-
依托单位:
Development of highly efficient homologous recombination system using mouse recombination genes and establishment of mouse strains with gene engineered
-
批准号:06454717
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.94万
-
财政年份:1994
-
负责人:MORITA Takashi
-
依托单位:
Urethral function and Aging
-
批准号:05671303
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1993
-
负责人:MORITA Takashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Entpd5在上皮性卵巢癌对Cisplatin继发耐药中的分子作用机制研究
-
批准号:81703078
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:黄莉萍
-
依托单位:
构建基于TRAIL-exosome的siRNA和Cisplatin共载纳米系统及治疗耐药宫颈癌的研究
-
批准号:81671809
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:朱雪琼
-
依托单位:
CUDC-101联合cisplatin对卵巢癌腹水细胞spheroid形成及转移机制的相关研究
-
批准号:81402127
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2014
-
负责人:孟凡良
-
依托单位:
NSAIDs增强卵巢癌细胞对顺铂、紫杉醇药物敏感性的机理研究
-
批准号:30772305
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2007
-
负责人:杨红
-
依托单位:
XPC表达变异改变膀胱尿路上皮癌对Cisplatin敏感性的实验研究
-
批准号:30340057
-
项目类别:专项基金项目
-
资助金额:9.0万元
-
批准年份:2003
-
负责人:陈志文
-
依托单位: